OPTIKINE
Live / Applied — New application — not yet assigned to an examiner (as of 28 Jul 2026)
What this means for you
Not registered yet, but its 28 Jul 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50018552
- Mark type
- Stylized text
- Filed
- 28 Jul 2026
- Attorney of record
- Dianne M. Smith-Misemer
Goods and services
- Class 001 — Chemicals: Recombinant cytokine proteins in raw material form for scientific and medical research use; Recombinant cytokine proteins for use in manufacture of pharmaceutical products, veterinary preparations, cellular therapies, gene therapies, regenerative medicines, and vaccines; Chemicals, namely, non-animal derived cell culture media for promoting cell growth, optimization, and productivity, for scientific and research use; Non-animal derived cell culture media for promoting cell growth, optimization, and productivity, for scientific, laboratory and medical research
- Class 005 — Pharmaceuticals: Chemicals, namely, non-animal derived cell culture media for promoting cell growth, optimization, and productivity, for medical or veterinary purposes; Recombinant cytokine proteins for use as cell growth media for growing cells for clinical use; Recombinant cytokine proteins for use as reagents for clinical medical purposes; Recombinant cytokine protein arrays for clinical medical diagnosis purposes; Recombinant cytokine proteins sold as a component ingredient of therapeutic pharmaceuticals for the treatment of immune system related diseases and disorders; Recombinant cytokine proteins for use as reagents for medical use, for the optimization of in vitro expansion of cells; Pharmaceutical preparations, namely, cytokine drugs for the optimization of in vitro expansion of cells
Owner
- InVitria, Inc., Junction City, KS, US
Prosecution history
- 28 Jul 2026 — APPLICATION FILING RECEIPT MAILED
- 28 Jul 2026 — NEW APPLICATION ENTERED